Election Outcome For House Health Committees
This article was originally published in RPM Report
Five members of the current Ways and Means Committee and eight members of the Energy and Commerce Committee will definitely be gone in the 113th Congress, including the chairman and ranking member of the Ways and Means Health Subcommittee.
You may also be interested in...
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.
FDA/CMS Summit speakers say they've yet to see any real interest from manufacturers in putting money at risk if their products don't meet outcome measures.